Uso antenatal de corticosteróide e evolução clínica de recém-nascidos pré-termo

Martinez, Francisco E; Linhares, Nelson J; Ferlin, Maria L. S; Marba, Sérgio; Netto, Abimael A; Procianoy, Renato S; Uchoa, Natacha T; Lopes, José Maria A; Bomfim, Olga; Guinsburg, Ruth; Almeida, Maria Fernanda B; Miyoshi, Milton; Meneguel, Joice F; Leone, Cléa R; Sadeck, Lílian S. R; Vaz, Flávio A. C; Fiori, Renato M; Fiori, Humberto H; Pereira, Manuel R; Trindade, Cleide E. P; Betlin, Maria R.
J. pediatr. (Rio J.) ; 80(4): 277-284, jul.-ago. 2004. tab
Artículo en Portugués | LILACS | ID: lil-391639

Documentos relacionados

  1. [Antenatal corticosteroid use and clinical evolution of preterm newborn infants].
  2. Plasma midregional proadrenomedullin in newborn infants: impact of prematurity and perinatal infection.
  3. Galectin-Levels Are Elevated in Infants Born Preterm Due to Amniotic Infection and Rapidly Decline in the Neonatal Period.
  4. Associations Between Maternal Antenatal Corticosteroid Treatment and Mental and Behavioral Disorders in Children.
  5. Antenatal corticosteroids and newborn respiratory outcomes in twins: A regression discontinuity study.
  6. Society for Maternal-Fetal Medicine Special Statement: Quality metrics for optimal timing of antenatal corticosteroid administration.
  7. Timing of antenatal corticosteroids and survival without neurologic disabilities at 5½ years in children born before 35 weeks of gestation.
  8. Antenatal corticosteroid therapy, delivery intervals and perinatal mortality in low-resource settings.
  9. The variation of antenatal corticosteroids administration for the singleton preterm birth in China, 2017 to 2018.
  10. Respiratory Morbidity in Late Preterm and Term Babies Born by Elective Caesarean Section.